GSK invests €12m in two new Irish API plants

By Dan Stanton contact

- Last updated on GMT

Image: iStock
Image: iStock

Related tags: Active pharmaceutical ingredients, Pharmacology, Pharmaceutical drug, Gsk

GSK has invested €12m ($14m) into a site in Ireland to develop and manufacture ingredients for its future portolio.

The site in Currabinny, Cork has been in operation since 1975 and currently manufactures nine active pharmaceutical ingredients (APIs) for GlaxoSmithKline’s pharma portfolio. Since then it has seen over €700m of investment from the firm.

But with this latest investment, GSK is looking at its future product range across diseases such as cancer, HIV and depression, the firm said, adding a €9.5m kilo-scale manufacturing facility and a €2.5m technical development laboratory.

“Our new Kilo Scale Facility represents an important new opportunity for GSK in Cork,”​ said the firm’s Head of Engineering Kevin O’Keefe. “The plant will expand our operating scale to allow us introduce new targeted medicines that require highly specialised manufacturing equipment.”

The Site Director, Joe Power, added the investment “demonstrates GSK’s strong commitment”​ to Cork and Ireland. “It’s a wonderful endorsement of the world-class technical capability we have here and will work to attract new business for the operation.”

The Currabinny site has seen a fair amount of drama over the past few years. In 2010​, GSK axed 121 jobs due to “changing market situations.”

And in 2014​, the site was hit with a US Food and Drug Administration (FDA) Warning Letter after inspectors found a number of GMP violations including equipment used to make API batches to be contaminated with material from [its] pharmaceutical waste tank​.”

This led to GSK issuing a recall of its antidepressant drug Paxil made at the site.

The FDA issued a close-out letter last August.

Related news

Show more

Related products

show more

LACTIUM®: dairy bioactive to soothe your pet

LACTIUM®: dairy bioactive to soothe your pet

Ingredia | 12-Oct-2021 | Infographic

Lactium® gives you the chance to better meet your pet’s needs for a more harmonious life together. Lactium® acts on the brain and has no side-effects,...

Facilities: Lexington, KY USA

Facilities: Lexington, KY USA

Piramal Pharma Solutions | 23-Aug-2021 | Insight Guide

The Piramal Pharma Solutions facility in Lexington, KY USA is a fully integrated site which offers analytical, formulation development, and manufacturing...

Related suppliers

Follow us


View more